Neurology

Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol

Julia C Greenland, Emma Cutting, Sonakshi Kadyan, Simon Bond, Anita Chhabra, Caroline H Williams-Gray

10.1136/bmjopen-2020-040527

November 23, 2020

Caesarean section and the association with migraine: a retrospective register-linked HUNT population cohort study

Espen Saxhaug Kristoffersen, Sigrid Børte, Knut Hagen, John-Anker Zwart, Bendik Slagsvold Winsvold

10.1136/bmjopen-2020-040685

November 18, 2020

A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia

Lucy Vivash, Charles B Malpas, Leonid Churilov, Mark Walterfang, Amy Brodtmann, Olivier Piguet, Rebekah M Ahmed, Ashley I Bush, Christopher M Hovens, T Kalincik, David Darby, Dennis Velakoulis, Terence J O'Brien

10.1136/bmjopen-2020-040100

November 16, 2020

ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis

Anne Kever, Katherine E Nelson, Ines M Aguerre, Claire S Riley, Amelia Boehme, Nancy W Lee, Rebecca Strauss Farber, Seth N Levin, Joel Stein, Victoria M Leavitt

10.1136/bmjopen-2020-039691

November 14, 2020

Effects of Creative Expressive Arts-based Storytelling (CrEAS) programme on older adults with mild cognitive impairment: protocol for a randomised, controlled three-arm trial

Rong Lin, Yuan-Jiao Yan, Yi Zhou, Yu-Ting Luo, Zhen-Zhen Cai, Kai-Yan Zhu, Hong Li

10.1136/bmjopen-2020-036915

November 11, 2020

Investigating a new tablet-based telerehabilitation app in patients with aphasia: a randomised, controlled, evaluator-blinded, multicentre trial protocol

Arif Sinan Uslu, Stephan M Gerber, Nadine Schmidt, Carina Röthlisberger, Patric Wyss, Tim Vanbellingen, Sandra Schaller, Corina Wyss, Monica Koenig-Bruhin, Thomas Berger, Thomas Nyffeler, René Müri, Tobias Nef, Prabitha Urwyler

10.1136/bmjopen-2020-037702

November 11, 2020

Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial

Michael J R Desborough, Rustam Al-Shahi Salman, Simon J Stanworth, Diane Havard, Paul M Brennan, Robert A Dineen, Timothy J Coats, Trish Hepburn, Philip M Bath, Nikola Sprigg

10.1136/bmjopen-2020-037555

November 10, 2020

Multicentre longitudinal study of fluid and neuroimaging BIOmarkers of AXonal injury after traumatic brain injury: the BIO-AX-TBI study protocol

Neil Samuel Nyholm Graham, Karl A Zimmerman, Guido Bertolini, Sandra Magnoni, Mauro Oddo, Henrik Zetterberg, Federico Moro, Deborah Novelli, Amanda Heslegrave, Arturo Chieregato, Enrico Fainardi, Joanne M Fleming, Elena Garbero, Samia Abed-Maillard, Primoz Gradisek, Adriano Bernini, David J Sharp

10.1136/bmjopen-2020-042093

November 10, 2020

Neuromonitoring with near-infrared spectroscopy (NIRS) in aneurysmal subarachnoid haemorrhage: a systematic review protocol

Mohamed Reda Bensaidane, Alexis F Turgeon, François Lauzier, Shane W English, Guillaume Leblanc, Charles L Francoeur

10.1136/bmjopen-2020-043300

November 10, 2020

Social burden of people with the migraine diagnosis in Japan: evidence from a population-based cross-sectional survey

Hisaka Igarashi, Kaname Ueda, Sungeun Jung, Zhihong Cai, Yirong Chen, Tomomi Nakamura

10.1136/bmjopen-2020-038987

November 9, 2020